Gynica focuses on clinically proven cannabis-based solutions in the field of women’s health. Gynica develops optimal therapeutic results, based on innovative technology and understanding of the pharmacological effects of different cannabinoids and compounds, targeted to specific diseases. Led by Professor Moshe Hod, an international leader in the field of women’s health, serving as the President of the European Association of Perinatal Medicine (EAPM) and Professor of Gynecology at the Tel Aviv University Faculty of Medicine.
The female reproductive system is the organ with the most endocannabinoid receptors in the human body, after the brain.
Gynica have absolute confidence in cannabinoids as an innovative lead to positively affect different gynecological disorders. Current treatments either fall short or are inefficient; Gynica offers a multisite intervention method to treat illnesses such as endometriosis, menstrual cramps, and more. To-date, only insufficient pain treatments are available on the market, yielding very limited effectiveness in the alleviation of women’s suffering. An ideal drug treatment would eliminate endometriotic lesions, prevent recurrence, reduce pain but not have any negative impact on the ovulation cycle. Advanced therapeutics capable of accomplishing these needs are required and Gynica has the tools to analyze and conceive positive solutions.